PeptiDream Inc
TSE:4587

Watchlist Manager
PeptiDream Inc Logo
PeptiDream Inc
TSE:4587
Watchlist
Price: 2 838 JPY 1.03% Market Closed
Market Cap: 367.8B JPY
Have any thoughts about
PeptiDream Inc?
Write Note

PeptiDream Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PeptiDream Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
PeptiDream Inc
TSE:4587
Cash from Investing Activities
ÂĄ9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Cash from Investing Activities
-ÂĄ9.8B
CAGR 3-Years
-239%
CAGR 5-Years
-56%
CAGR 10-Years
-45%
Takara Bio Inc
TSE:4974
Cash from Investing Activities
-ÂĄ13.1B
CAGR 3-Years
-179%
CAGR 5-Years
-34%
CAGR 10-Years
-1%
Pharma Foods International Co Ltd
TSE:2929
Cash from Investing Activities
-ÂĄ1.4B
CAGR 3-Years
-47%
CAGR 5-Years
-36%
CAGR 10-Years
-23%
S
StemRIM Inc
TSE:4599
Cash from Investing Activities
-ÂĄ4.8m
CAGR 3-Years
63%
CAGR 5-Years
6%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Cash from Investing Activities
-ÂĄ35m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PeptiDream Inc
Glance View

Market Cap
367.8B JPY
Industry
Biotechnology

PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken and currently employs 141 full-time employees. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).

Intrinsic Value
2 339.75 JPY
Overvaluation 18%
Intrinsic Value
Price

See Also

What is PeptiDream Inc's Cash from Investing Activities?
Cash from Investing Activities
9B JPY

Based on the financial report for Sep 30, 2024, PeptiDream Inc's Cash from Investing Activities amounts to 9B JPY.

What is PeptiDream Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
555%

Over the last year, the Cash from Investing Activities growth was 555%.

Back to Top